Fig. 1. MYCN and CD71 expression in INSS stage 4 neuroblastoma patients. Scatter plots are shown for expression of MYCN and CD71 in neuroblastoma patient cohorts. The R2 platform was used for the calculation, and the AMC cohort (n=88) "Neuroblastoma public-Versteeg −88" (A) as well as the Cologne cohort (n=649; also subdivided to cohorts with various INSS stages) "Neuroblastoma-Kocak −649" (B-F). (G-H) Kaplan-Meier curves were generated from the survival data for neuroblastoma patients with tumor samples quantified for MYCN and CD71 expression. The data were from the cited cancer databases according to Materials and Methods.